Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Live Nation Entertainment, Inc. (LYV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Live Nation Entertainment, Inc. — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Live Nation Entertainment, Inc. trades at $170.33 (market cap $39.92B). The key difference: Live Nation Entertainment, Inc. is far larger — about 3.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Live Nation Entertainment, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Live Nation Entertainment, Inc. for 72 Days on average.
| HALO | LYV | |
|---|---|---|
Market Cap | $12.58B | $39.92B |
Volume | 2,179,278 | 1,982,609 |
Sector | Health | Media |
52-Week High | $115.22 | $188.46 |
52-Week Low | $61.63 | $125.61 |
Typical Hold Time | 1 Days | 72 Days |
Enterprise Value | $14.49B | $42.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Live Nation Entertainment (LYV) trades at $171.34, up 0.29% with a bullish technical signal and strong analyst support. The company reported mixed Q2 2026 earnings with a beat on EPS but faces valuation concerns with a P/E of 117.49 and negative ROE of -116.65%. Recent news highlights strong consumer demand for live events and strategic partnerships, though insider selling and regulatory scrutiny present headwinds.
The outlook remains positive with 87% analyst buy ratings and a $208.18 price target, representing 21% upside. Key risks include high debt levels, margin pressure, and ongoing regulatory challenges. Revenue growth continues with 2026 projections of $26.3B, but profitability metrics need improvement for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →
